T cell mediated hypersensitivity to previously tolerated iodinated contrast media precipitated by introduction of atezolizumab

Many adverse reactions associated with immune checkpoint inhibitor (ICI) treatments are immunologically driven and may necessitate discontinuation of the ICI. Herein, we present a patient who had been administered the radio contrast media amidotrizoate multiple times without issue but who then devel...

Descripción completa

Detalles Bibliográficos
Autores principales: Hammond, Sean, Olsson-Brown, Anna, Gardner, Joshua, Thomson, Paul, Ali, Serat-E, Jolly, Carol, Carr, Dan, Ressel, Lorenzo, Pirmohamed, Munir, Naisbitt, Dean
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2021
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8166637/
https://www.ncbi.nlm.nih.gov/pubmed/34049931
http://dx.doi.org/10.1136/jitc-2021-002521

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8166637/
https://www.ncbi.nlm.nih.gov/pubmed/34049931
http://dx.doi.org/10.1136/jitc-2021-002521

Ejemplares similares